[Effects of tachykinin antagonists on inflammation].
Lundberg
J M
JM
Institutionen för fysiologi och farmakologi, Karolinska institutet, Stockholm.
D000700:Analgesics / Q000737:chemistry / Q000494:pharmacology; D000818:Animals; D001713:Biphenyl Compounds / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D006993:Hypnotics and Sedatives / Q000737:chemistry / Q000494:pharmacology; D007211:Indoles / Q000737:chemistry / Q000494:pharmacology; D007249:Inflammation / Q000503:physiopathology* / Q000517:prevention & control; D054833:Isoindoles; D051381:Rats; D018040:Receptors, Neurokinin-1 / Q000187:drug effects; D018041:Receptors, Neurokinin-2 / Q000187:drug effects; D018039:Receptors, Tachykinin / Q000187:drug effects*; D014132:Trachea / Q000187:drug effects
D000700:Analgesics; D001713:Biphenyl Compounds; D006993:Hypnotics and Sedatives; D007211:Indoles; D054833:Isoindoles; D018040:Receptors, Neurokinin-1; D018041:Receptors, Neurokinin-2; D018039:Receptors, Tachykinin; C071693:7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one; C066892:CP 96345
Effekter av takykinin-antagonister på inflammation.